Shares of Schmid Group (SHMD) fell 11.4% to $5.64, pressured by broader market declines and weakening technical momentum. The stock is trading below its 20-day and 100-day moving averages, signaling short-term bearishness, though it remains above its 200-day average, indicating no long-term breakdown yet. Key support is at $5.50, with resistance near $6.00. Market conditions, including a down Russell 2000 and defensive sector underperformance, are contributing to the stock's decline. Investors should watch if SHMD breaks below support or recovers above resistance to gauge future momentum.
DelveInsight's 2026 report reveals a robust pipeline with 75+ drugs under development for Duchenne muscular dystrophy (DMD), involving 70+ companies. Key therapies focus on gene and mutation-targeted approaches to slow disease progression, addressing...
Eramet has appointed Simon Henochsberg as its new Group Chief Financial Officer and member of the Executive Committee, effective May 26, 2026. Henochsberg, who previously served as Vice President of Group Strategy and co-Chief Financial Officer, brin...
Funnel has introduced Digital Measurement, a new marketing mix modeling (MMM) software that integrates MMM, Multi-Touch Attribution (MTA), and ad platform signals into one calibrated system. This approach addresses the limitations of relying on a sin...
Zealand Pharma held an Extraordinary General Meeting on May 26, 2026, where all proposals were approved, including the election of Camilla Sylvest to the Board of Directors. The board now consists of seven shareholder-elected members and four employe...
Nvidia has been a top AI investment as demand for AI chips surged, but the next wave of IPOs from major AI customers like SpaceX, OpenAI, and Anthropic could shift investor focus. These companies, while not competitors in hardware, may compete for in...
